Reply to "Comments on chemoradiotherapy in IDH wild-type/TERT-mutant grade 2/3 gliomas". Zhang J, Wang P, Ren Y, Chen L, et al. Cancer 2026;132:e70359.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Zhang J, Wang P, Ren Y, Chen L, et al. Reply to "Comments on chemoradiotherapy in IDH wild-type/TERT-mutant grade 2/3 gliomas". Cancer 2026;132:e70359.
PMID: 41982092